Denmark, Norway and Iceland took a break on Thursday over the use of AstraZeneca’s COVID-19 vaccine following reports of some patients developing blood clots after receiving the shot, according to Reuters.
Authorities in Denmark have suspended the use of the vaccine for two weeks after a 60-year-old woman who was shot received a blood clot and died.
Our country is in a historic battle against the Coronavirus. Add Changing America to you Facebook or Twitter feed to stay up to date with the news.
She reportedly received a shot from the same group of vaccines used in Austria, where authorities announced on Monday that they would no longer use doses from the burst after the death of a nurse who had blood clotting problems days after she vaccinated. A second woman who received a vaccine was also admitted to hospital after suffering from pulmonary embolism and recovering.
‘It is not currently possible to determine if there is a link. We [are acting] it must be thoroughly investigated early, “said Danish Health Minister Magnus Heunicke. Twitter.
Iceland and Norway followed suit on Thursday as an investigation into the reports is being conducted by the European Medicines Regulator, the European Medicines Agency (EMA). Estonia, Lithuania, Luxembourg and Latvia also suspended vaccinations from the group.
Italy also said it would stop using a group other than the one in Austria.
While the incidents have led European countries to take precautions, health officials say there is little evidence to suggest that the vaccine should not be given.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine,” EMA said in a statement. statement.
“The position of the EMA’s safety committee, PRAC, is that the benefits of the vaccine still outweigh the risks and that the vaccine can be administered while investigating cases of thromboembolic events.”
AstraZeneca said the safety of the vaccine has been extensively studied in clinical trials and meets the strict efficacy and safety standards required by regulators.
The vaccine has not yet received permission for emergency use in the US
WHAT YOU NEED TO KNOW ABOUT CORONAVIRUS NOW
NEW STUDY WARNINGS PFIZER AND MODERNA COVID-19 BELKING SUBSTANCES MAY BE FAR LESS EFFECTIVE TO SOUTH AFRICA VARIANT
1 IN 4 AMERICANS REFUSE TO GET COVID-19 VACCINE: POLL
ALASKA BECOMES FIRST STATE TO OPEN BULKSTONS FOR ADULTS OF ANY AGE
YOU ARE SO FULLY AGAINST COVID-19. NOW WHAT?
CALIFORNIA DISTRICT 40 PERCENT OF ITS COVID-19 INSTRUMENTS FOR VULNERABLE COMMUNITIES